AMP-220

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameAMP-220
Drug Alias NameGut-targeted IL-22 AND-Body™ therapeuticAMP-220AMP220
ClassificationBiologics
Mechanisms of ActionInterleukin-22 modulators
TargetsInterleukin-22
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmpersand Biomedicines
China Registration ClassN/A

Develop Information

Active CompaniesAmpersand Biomedicines
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A